Regeneron Pharmaceuticals (REGN.VI) Q4 2017 Earnings

8NovConfirmed
Q1 2017
Q2 2017
Q3 2017
Q4 2017
2.66
2.94
3.23
3.51

Details

Expected EPS
3.2940623999999996
Actual EPS
3.4406568
Surprise EPS
0.15
Surprise Percent
+4.45%

Description

Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 3.4406568 per share for Q4 2017.

0 Comments

Share your thoughts